Recombinant multi-species PABPN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PABPN1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an abundant nuclear protein that binds with high affinity to nascent poly(A) tails. The protein is required for progressive and efficient polymerization of poly(A) tails at the 3' ends of eukaryotic transcripts and controls the size of the poly(A) tail to about 250 nt. At steady-state, this protein is localized in the nucleus whereas a different poly(A) binding protein is localized in the cytoplasm. This gene contains a GCG trinucleotide repeat at the 5' end of the coding region, and expansion of this repeat from the normal 6 copies to 8-13 copies leads to autosomal dominant oculopharyngeal muscular dystrophy (OPMD) disease. Related pseudogenes have been identified on chromosomes 19 and X. Read-through transcription also exists between this gene and the neighboring upstream BCL2-like 2 (BCL2L2) gene. [provided by RefSeq, Dec 2010]
The Alternative Names of target: Nuclear poly(A)-binding protein 1,OPMD,PAB2,PABII,PABP-2,PABP2,PABPN1,Pabp3,Pabpn1,Poly(A)-binding protein 2,Poly(A)-binding protein II (PABII),Polyadenylate-binding nuclear protein 1,Polyadenylate-binding protein 2,mPABII
Go
to PABPN1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP12519-Ag-1/ GM-Tg-hg-IP12519-Ag-2 | Human PABPN1 protein | Human |
| GM-Tg-rg-IP12519-Ag-1/ GM-Tg-rg-IP12519-Ag-2 | Rat PABPN1 protein | Rat |
| GM-Tg-mg-IP12519-Ag-1/ GM-Tg-mg-IP12519-Ag-2 | Mouse PABPN1 protein | Mouse |
| GM-Tg-cynog-IP12519-Ag-1/ GM-Tg-cynog-IP12519-Ag-2 | Cynomolgus/Rhesus macaque PABPN1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP12519-Ag-1/ GM-Tg-felg-IP12519-Ag-2 | Feline PABPN1 protein | Feline |
| GM-Tg-cang-IP12519-Ag-1/ GM-Tg-cang-IP12519-Ag-2 | Canine PABPN1 protein | Canine |
| GM-Tg-bovg-IP12519-Ag-1/ GM-Tg-bovg-IP12519-Ag-2 | Bovine PABPN1 protein | Bovine |
| GM-Tg-equg-IP12519-Ag-1/ GM-Tg-equg-IP12519-Ag-2 | Equine PABPN1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP12519-Ag-1/ GM-Tg-hg-IP12519-Ag-2;
GM-Tg-rg-IP12519-Ag-1/ GM-Tg-rg-IP12519-Ag-2;
GM-Tg-mg-IP12519-Ag-1/ GM-Tg-mg-IP12519-Ag-2; GM-Tg-cynog-IP12519-Ag-1/ GM-Tg-cynog-IP12519-Ag-2; GM-Tg-felg-IP12519-Ag-1/ GM-Tg-felg-IP12519-Ag-2; GM-Tg-cang-IP12519-Ag-1/ GM-Tg-cang-IP12519-Ag-2; GM-Tg-bovg-IP12519-Ag-1/ GM-Tg-bovg-IP12519-Ag-2; GM-Tg-equg-IP12519-Ag-1/ GM-Tg-equg-IP12519-Ag-2 |
| Products Name | PABPN1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | PABPN1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PABPN1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.